
Veterinary/Animal Vaccines Market Share
Veterinary (Animal) Vaccines Market Research Report Information By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2032

Market Summary
The Global Veterinary Vaccines Market is projected to grow from 6.27 USD Billion in 2024 to 15.4 USD Billion by 2032.
Key Market Trends & Highlights
Veterinary (Animal) Vaccines Key Trends and Highlights
- The market is expected to experience a compound annual growth rate of 8.48 percent from 2024 to 2032. By 2032, the market valuation is anticipated to reach 15.4 USD Billion, indicating robust growth potential. In 2024, the market is valued at 6.27 USD Billion, reflecting a strong foundation for future expansion. Growing adoption of advanced vaccination technologies due to increasing awareness of animal health is a major market driver.
Market Size & Forecast
2024 Market Size | 6.27 (USD Billion) |
2032 Market Size | 15.4 (USD Billion) |
CAGR (2024-2032) | 8.48% |
Largest Regional Market Share in 2024 | latin_america) |
Major Players
<p>Zoetis, Virbac SA, Merck, Phibro Animal Health Corporation, Boehringer Ingelheim, Ceva, Elanco</p>
Market Trends
Drivers
As the middle classes around the world explode, so does the preference to keep pets. Most people keep cats and dogs as pets.. These pets need vaccines in order to stay healthy. This is one large driver of growth in the veterinary/animal vaccines market.
Growing middle classes around the world means that the demand for meat consumption is rising dramatically around the world. This raises the importance of veterinary vaccines because farm animals need to be vaccinated before they are slaughtered for human consumption.
This keeps the meat healthier and helps it last longer. It also keeps animals from developing dangerous bacteria, parasites, and viruses that can harm or even kill humans. In fact, according to the international veterinary vaccines and diagnostics conference 2006 the demand for various types of animal vaccines will increase dramatically in later years.
Opportunities
There are many emerging opportunities in the veterinary/animal vaccines market. Many veterinary clinics are investing heavily in research and development to develop and market more advanced vaccines that will keep animals healthier and stronger and help them live longer.
Vaccines for animals are also getting a strong boost from technological advancements. It’s advancements in technology that promise to make a new generation of stronger animal vaccines that are much more effective and last longer.
Research and development will also allow vaccine manufacturers to develop and market hybrid vaccines. These will be much more effective, hence they will be extremely profitable.
Restraints
All vaccines have side effects. Animal vaccines are no exception. This is a key restraint in the veterinary/animal vaccines market. Most farmers and pet owners are loath to get their animals vaccinated because they are all too aware of the side effects but they are not aware enough of the benefits of these vaccines. Most farmers don’t get their animals vaccinated for this reason. This is the case in developing nations.
The animal vaccine market is also heavily regulated. This is another factor that’s holding back growth in the Veterinary (Animal) Vaccines Market.
Challenges
Some animal vaccines for some segments of animals are very expensive. This factor is a major challenge in the veterinary/animal vaccines market. Animal vaccine manufacturers will also have to find ways to better educate animal owners about the benefits of animal vaccines.
Technology analysis
Merck is a major American player in the Veterinary (Animal) Vaccines Market. It became an industry leader by creating a sustainable competitive advantage. Intensive investments in research and development have allowed it to do this. In the field of animal research, the value of vaccines has been established significantly.
Animals and pets have both been immunized for many years. In the near future, beekeepers might be able to immunize their colonies. As of October 2022, the first honeybee vaccine in the world is being developed by the University of Georgia College of Agricultural and Environmental Sciences (CAES) and Dalan Animal Health.
<p>The ongoing advancements in veterinary vaccine development are poised to enhance animal health outcomes and may contribute to the overall sustainability of livestock production systems.</p>
U.S. Department of Agriculture (USDA)
Veterinary/Animal Vaccines Market Market Drivers
Rising Pet Ownership
The increasing trend of pet ownership globally is a primary driver for the Global Veterinary Animal Vaccines Market Industry. As more households adopt pets, the demand for veterinary services, including vaccinations, rises significantly. In 2024, the market is valued at 6.27 USD Billion, reflecting the growing concern among pet owners for their animals' health. This trend is particularly pronounced in urban areas, where pet ownership rates have surged. Consequently, the need for effective vaccines to prevent diseases in pets is becoming more critical, thereby propelling the market forward.
Market Growth Projections
The Global Veterinary Animal Vaccines Market Industry is projected to experience substantial growth in the coming years. With a market value of 6.27 USD Billion in 2024, it is anticipated to reach 15.4 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 8.48% from 2025 to 2035. Such projections reflect the increasing demand for veterinary vaccines driven by factors such as rising pet ownership, advancements in vaccine technology, and heightened awareness of animal health. The market's expansion is indicative of the critical role that vaccines play in ensuring the health and well-being of animals globally.
Emerging Zoonotic Diseases
The emergence of zoonotic diseases is a significant driver for the Global Veterinary Animal Vaccines Market Industry. As new diseases that can be transmitted from animals to humans arise, there is an urgent need for effective vaccination strategies to control outbreaks. This concern is particularly relevant in regions where livestock and wildlife interactions are frequent. The increasing incidence of such diseases highlights the necessity for robust vaccination programs, thereby propelling market growth. The focus on preventing zoonotic diseases is expected to contribute to the overall expansion of the market in the coming years.
Regulatory Support and Standards
Regulatory frameworks and standards established by government agencies play a crucial role in shaping the Global Veterinary Animal Vaccines Market Industry. Governments worldwide are implementing stringent regulations to ensure the safety and efficacy of veterinary vaccines. This regulatory support fosters consumer confidence and encourages veterinarians to adopt new vaccines. Moreover, compliance with these regulations often leads to improved product quality, which can enhance market growth. As the industry evolves, adherence to these standards will likely remain a key driver for the market, ensuring that animal health is prioritized.
Advancements in Vaccine Technology
Technological advancements in vaccine development are transforming the Global Veterinary Animal Vaccines Market Industry. Innovations such as recombinant vaccines and mRNA technology are enhancing vaccine efficacy and safety. These advancements not only improve the immune response in animals but also reduce the incidence of adverse effects. As a result, veterinarians are more likely to recommend these modern vaccines, further driving market growth. The anticipated market expansion to 15.4 USD Billion by 2035 underscores the importance of these technological developments in meeting the evolving needs of animal health.
Increased Awareness of Animal Health
There is a growing awareness among pet owners and livestock producers regarding the importance of animal health, which significantly influences the Global Veterinary Animal Vaccines Market Industry. Educational campaigns and outreach programs by veterinary associations have heightened understanding of the benefits of vaccinations. This awareness leads to increased vaccination rates, thereby reducing the prevalence of infectious diseases in animals. As the market continues to expand, the projected compound annual growth rate of 8.48% from 2025 to 2035 indicates that this trend will likely persist, further solidifying the role of vaccines in animal health.
Market Segment Insights
Veterinary/Animal Vaccines Type Insights
<p>The veterinary/animal vaccines market can be grouped into the following sub-segments by type:</p>
<p>The attenuated vaccines sub-segment held the highest market share last year because they do a better job of boosting animals’ immune systems than other vaccines do. Also, animals who get attenuated vaccines need fewer booster shots less often. Most booster vaccines are given to animals orally. </p>
<p>This makes them less effective in strengthening the animals’ immune systems and keeping them healthier than vaccines that are given by injection. </p>
Veterinary/Animal Vaccines Disease Insights
<p>The Veterinary (Animal) Vaccines Market can be grouped into the following sub-segments by disease:</p>
Veterinary/Animal Vaccines Technology Insights
<p>The Veterinary (Animal) Vaccines Market can be grouped into the following sub-segments by type:</p>
<p>By Type (Livestock)</p>
<p>The Department of Animal Husbandry and Dairying (DAHD) advised states to immunize cattle and buffaloes with the available Goat pox vaccine on September 20, 2021, despite the fact that lumpy skin disease has already killed almost 1 lakh cattle and infected over 20 lakh animals across 15 states. The only manufacturer of the goatpox vaccine in the nation at the time of authorization was Hester Biosciences in Gujarat; IIL, the Hyderabad-based Brilliant Bio Pharma Pvt Ltd, introduced its goatpox vaccine in December 2021.</p>
Get more detailed insights about Veterinary (Animal) Vaccines Market Research Report - Forecast till 2032
Regional Insights
Key Companies in the Veterinary/Animal Vaccines Market market include





Industry Developments
- Many key companies in the Veterinary (Animal) Vaccines Market have stayed successful by entering into strategic partnerships with other successful companies. They have managed to develop a new vaccine for poultry (chicks to be exact). This is very effective so it has great revenue generation potential.
- Big companies are partnering up to develop new aquaculture vaccines that will do a better job of protecting aquatic life from diseases.
- Elanco acquired a new animal vaccine company as part of its expansion strategy
Future Outlook
Veterinary/Animal Vaccines Market Future Outlook
<p>The Veterinary (Animal) Vaccines Market is projected to grow at an 8.48% CAGR from 2024 to 2032, driven by increasing pet ownership, advancements in vaccine technology, and rising awareness of animal health.</p>
New opportunities lie in:
- <p>Develop personalized vaccines targeting specific animal breeds. Leverage digital platforms for vaccine distribution and education. Invest in R&D for innovative adjuvants to enhance vaccine efficacy.</p>
<p>By 2035, the Veterinary (Animal) Vaccines Market is expected to achieve substantial growth, reflecting evolving industry dynamics.</p>
Market Segmentation
Report Scope
Attribute/Metric | Details |
Market Size 2032 | 11.8 (USD) Billion |
CAGR | 9.2% (2023-2032) |
Base Year | 2023 |
Forecast Period | 2023-2032 |
Historical Data | 2020 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Technology, Region |
Geographies Covered | North America, Europe, Asia-Pacific, Rest of the World |
Key Vendors | Zoetis (US), Virbac SA (France), Merck (US), Phibro Animal Health Corporation (US), Boehringer Ingelheim (Germany), Ceva (France), Elanco (US) |
Key Market Opportunities | · High development opportunities in the upcoming years · Technological developments |
Key Market Drivers | · The increasing rate of pet adoption · Rising expenditure on the pet treatment · High consumption of meat |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
Which regions will have the highest CAGR in veterinary/animal vaccines market?
North America and Asia-Pacific
What are the recent trends in the veterinary/animal vaccines market?
More technological advancement is leading to better and more innovative vaccines
Who are the key competitors in the veterinary/animal vaccines market?
Zoetis (US), Virbac SA (France), Merck (US), Phibro Animal Health Corporation (US), Boehringer Ingelheim (Germany), Ceva (France), Elanco (US)
-
List of Tables and Figures
Veterinary (Animal) Vaccines Market Segmentation
Market Segmentation Overview
- Detailed segmentation data will be available in the full report
- Comprehensive analysis by multiple parameters
- Regional and country-level breakdowns
- Market size forecasts by segment

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment